Adial Pharmaceuticals's total assets for Q4 2023 were $4.74M, an increase of 65.19% from the previous quarter. ADIL total liabilities were $653.08K for the fiscal quarter, a 23.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.